ADT has acquired a license to commercialize and market a patent protected software technology that can analyze the brain faster and more accurately using 3D mesh mapping to determine significant locations that correlate with brain structure and disease. The new technology can diagnose Autism in infants as young as six months old at 90%+ rate of accuracy, and it is also effective for diagnosing Dyslexia, Dementia and Alzheimer’s disorders.